Clinical Trial Update: Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Results from a Phase 3 trial of netarsudil ophthalmic solution in glaucoma or ocular hypertension have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Netarsudil (AR-13324) ophthalmic solution (netarsudil)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Ocular Hypertension, Glaucoma | Phase 3 | Status: COMPLETED | Results posted: 2018-04-06